Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neocodion misuse: evolution between 1992 and 2002].

Catherine Armand1, Xavier Thirion, Carine Saillard

  • 1Centre d'Evaluation et d'Information sur la Pharmacodépendance de Nancy (Alsace-Lorraine, Bourgogne, Franche-Comté, Champagne-Ardennes), Hôpital Central, Nancy, France. c.armand-malaplate@chu-nancy.fr

Therapie
|January 15, 2005
PubMed
Summary

Neocodion misuse significantly decreased between 1992 and 2002, with fewer pharmacy requests and lower consumption rates. Despite this decline, vigilance is needed due to continued psychoactive use, often alongside other drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Socioeconomic deprivation, disease complications and access to preventive care in sickle cell disease in mainland France.

Annals of hematology·2026
Same author

Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study.

The Lancet. Public health·2026
Same author

Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase<sup>®</sup> Data.

CNS drugs·2026
Same author

Medication reconciliation at patient admission in psychiatric setting: prioritisation tool to reduce medication errors (O-PsyConcil).

European journal of hospital pharmacy : science and practice·2026
Same author

Risk of thrombosis in adults with primary immune thrombocytopenia treated with eltrombopag vs romiplostim: a target trial emulation in the French Adult Immune Thrombocytopenia (FAITH) cohort.

Journal of thrombosis and haemostasis : JTH·2026
Same author

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study.

Haematologica·2026

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Public Health

Background:

  • Neocodion, a codeine-based antitussive, has a history of misuse by opiate addicts.
  • Understanding trends in Neocodion misuse is crucial for public health interventions.

Purpose of the Study:

  • To analyze the evolution of Neocodion misuse in France from 1992 to 2002.
  • To identify changes in consumption patterns and user demographics.

Main Methods:

  • Conducted three pharmacist network surveys in 1992, 1997, and 2002.
  • Utilized data from the French drug-dependence monitoring program (OPPIDUM).

Main Results:

  • Observed a significant decrease in Neocodion consumption, with pharmacy requests dropping from 9.9 to 2.1 per week.

Related Experiment Videos

  • Neocodion consumption rate reduced from 8% to 0.4% between 1992 and 2002.
  • Users were older, had better socioeconomic conditions, and 86% were poly-drug consumers, seeking psychoactive effects over opiate maintenance.

    • Conclusions:

    • Neocodion consumption has markedly declined over the decade studied.
    • Shifting patterns indicate misuse for psychoactive effects rather than opiate substitution.
    • Continued monitoring and vigilance are necessary despite the observed reduction in misuse.